COMBINATION THERAPY OF A GPRC5D TCB AND CD38 ANTIBODIES Application WO-2024079010-A1 World Intellectual Property Organisation (WIPO) 18 Apr 2024
BI-SPECIFIC BINDING AGENTS TARGETING SYNDECAN-1 AND FIBROBLAST GROWTH FACTOR RECEPTOR Application EP-3861117-A4 European Patent Office 11 Jan 2023
BISPECIFIC ANTIBODY BINDING TO BCMA AND CD3, AND PREPARATION METHOD THEREFOR AND USE… Application WO-2022267702-A1 World Intellectual Property Organisation (WIPO) 29 Dec 2022
MULTI-SPECIFIC ANTIBODIES BINDING TO BCMA Application WO-2022006316-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022